The underwriters for Karolinska Institute spinout Aprea Therapeutics have taken up the over-allotment option in full to boost proceeds to nearly $97.8m.

The underwriters for Praktikertjänst-backed Aprea Therapeutics have taken up the over-allotment option in full to boost proceeds to nearly $97.8m.

Novo Holdings co-led a series C round for orthodontic brace technology developer Swift Health Systems, which has now raised more than $70m.

Ajax Health has led a $25m series A round for medical device manufacturer EP Map System.

University of Oxford-founded autoimmune disease therapy developer MiroBio has launched with support from OSI and GlaxoSmithKline’s SR One.

University of Oxford-founded autoimmune disease therapy developer MiroBio has launched with support from GlaxoSmithKline subsidiary SR One.

LG Technology Ventures and existing investors Novo, SR One and Takeda Ventures all took part in a round that will support the advance of Arcellx's immuno-oncology cell therapies.

The AstraZeneca-backed cancer drug developer had hoped to raise up to $212m in a US flotation but is instead pulling back due to unfavourable market conditions.

Endoscopic software developer AI Medical Service raised $42.9m from investors including Sony Innovation Fund and Globis Capital Partners to take its overall funding to $57m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.